Valeant Pharmaceuticals (VRX) volatility stays elevated after less than expected Q3 and outlook

Valeant Pharma (NYSE: VRX) November weekly call option implied volatility is at 142, November is at 116, December is at 95; compared to its 52-week range of 53 to 173 after reporting less than expected Q3 results and outlook

You May Also Be Interested In

• Google Cloud, Accenture Launch Unit to Put AI Engineers On-Site With Customers - WSJ
• Biomea Fusion, Inc. (BMEA) January 2.5 calls active
• Southern Copper Corp. (SCCO) call put ratio 1 call 1 put amid copper near all-time high